Xiaojing Zhao
4PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Nov 28, 2024
YY1 downregulation underlies therapeutic response to molecular targeted agents.Shichao Zhou, Jingyu Zang, Mei-Chun Cai
|Sep 28, 2022
Transient targeting of BIM-dependent adaptive MCL1 preservation enhances tumor response to molecular therapeutics in non-small cell lung cancer.Kaixuan Shi, Haijiao Lu, Zhenfeng Zhang
|Aug 29, 2022
Network-Based Pharmacological Study on the Mechanism of Action of Buxue Liqi Huatan Decoction in the Treatment of Lung Cancer.Huabing Wei, Lihuang Zhou, Xiaojing Zhao
|Aug 12, 2021
USP12 downregulation orchestrates a protumourigenic microenvironment and enhances lung tumour resistance to PD-1 blockade.Zhaojuan Yang, Guiqin Xu, Boshi Wang
Pageof 1
